StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
7
Publishing Date
2023 - 04 - 10
1
2023 - 01 - 16
1
2022 - 11 - 22
1
2022 - 02 - 23
1
2022 - 02 - 07
1
2021 - 10 - 07
1
2021 - 10 - 06
1
Sector
Health technology
7
Manufacturing
1
N/a
1
Producer manufacturing
1
Tags
Agreement
8
Alzheimer's
10
America
67
Antibody
8
Application
8
Approval
13
Biosimilar
32
Breast
13
Business
9
Cancer
91
Cell
9
Chmp
10
Diabetes
15
Diagnostics
17
Disease
61
Drug
85
Earnings
18
Europe
15
Expansion
10
Expected
35
Eye
15
Fda
22
Financial
24
Global
228
Growing
43
Growth
235
Health
19
Immunotherapy
11
Infection
9
Kisqali
11
Leukemia
10
Liver
11
Market
592
N/a
945
Novartis
132
People
13
Pharma
13
Pharmaceuticals
17
Pipeline
12
Positive
15
Potential
10
Reach
34
Report
194
Research
118
Respiratory
11
Results
38
Risk
10
Sales
9
Sclerosis
13
Set
15
Study
15
T-cell
11
Technology
12
Therapeutics
109
Therapy
64
Treatment
113
Trial
16
Update
10
Vaccine
10
Year
12
Entities
Abbott laboratories
1
Alimera sciences, inc.
1
Ampio pharmaceuticals, inc.
1
Astellas pharma inc
1
Astrazeneca plc
1
Eli lilly and company
1
Idex corporation
1
Iridex corporation
1
Johnson & johnson
1
Kodiak sciences inc
1
Novartis ag
7
Pfizer, inc.
2
Reata pharmaceuticals, inc.
1
Regeneron pharmaceuticals, inc.
2
Sanofi
1
Staar surgical company
1
Symbols
ABT
4
ADVM
1
ALBT
1
ALIM
3
ALPMF
1
ALPMY
1
ALRT
1
ALRTF
1
ALT
1
AMPE
1
AMPED
1
ANSS
1
APLT
8
APTX
3
ARTH
1
AVCO
1
AZN
2
AZNCF
1
BAX
2
BDX
3
BMEA
2
CLPBF
2
CLPBY
2
CLSD
6
DNAC
2
EVOK
2
EYPT
3
IEX
2
IRIX
2
JNJ
4
K
2
KOD
8
LLY
7
LXRX
7
MDT
3
NURO
2
NVO
3
NVRO
11
NVS
9
NVSEF
7
OCS
6
OCUL
3
OCUP
7
PFE
2
PTE
3
PTN
3
REGN
13
RGNX
8
RNLX
2
RZLT
6
SNNUF
4
SNY
16
SNYNF
13
SRZN
2
TEVJF
2
UBX
5
UL
4
UNLYF
3
VRTX
2
ZVSA
5
Exchanges
Amex
1
Nasdaq
7
Nyse
7
Crawled Date
2023 - 04 - 10
1
2023 - 01 - 16
1
2022 - 11 - 22
1
2022 - 02 - 23
1
2022 - 02 - 07
1
2021 - 10 - 07
1
2021 - 10 - 06
1
Crawled Time
03:00
1
10:00
1
12:00
1
13:00
1
13:15
1
15:20
1
16:00
1
Source
www.prnewswire.com
7
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Diabetic
symbols :
NVSEF
save search
Painful Diabetic Neuropathy Drugs Market Report 2022: Featuring Daiichi Sankyo Company, Eli Lilly and Company, Johnson & Johnson Services, Novartis & More
Published:
2023-04-10
(Crawled : 15:20)
- prnewswire.com
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
16.8%
|
O:
-3.01%
H:
2.09%
C:
2.09%
NVS
|
News
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-3.3%
|
O:
-0.29%
H:
0.02%
C:
-0.29%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-12.34%
|
O:
-0.31%
H:
0.13%
C:
-0.19%
LLY
|
News
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
103.85%
|
O:
-0.03%
H:
0.04%
C:
-0.32%
report
novartis
market
diabetic
Diabetic Macular Edema Treatment Global Market Report 2022: Prevalence of Diabetes Worldwide Bolsters Sector
Published:
2023-01-16
(Crawled : 12:00)
- prnewswire.com
IEX
|
$226.1
-0.32%
0.0%
250K
|
Producer Manufacturing
|
Email alert
Add to watchlist
REGN
|
$893.66
-0.84%
-0.84%
450K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
Email alert
Add to watchlist
IRIX
|
$2.97
-6.6%
-7.07%
38K
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
treatment
global
report
macular
diabetes
market
diabetic
The Worldwide Diabetic Retinopathy Industry is Expected to Reach $7.7 Billion by 2027 at a 11.3% CAGR
Published:
2022-11-22
(Crawled : 13:00)
- prnewswire.com
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
-47.24%
|
O:
0.33%
H:
1.88%
C:
1.53%
NVS
|
News
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
7.25%
|
O:
0.77%
H:
0.41%
C:
0.27%
REGN
|
$893.66
-0.84%
-0.84%
450K
|
Health Technology
|
21.95%
|
O:
0.66%
H:
0.79%
C:
0.72%
ALIM
|
$3.4
-4.23%
-4.41%
57K
|
Health Technology
|
-15.57%
|
O:
0.47%
H:
7.5%
C:
-1.17%
expected
diabetic
Intraocular Lens Market to Expand Owing to Rise in Diabetic Population, States TMR Study
Published:
2022-02-23
(Crawled : 03:00)
- prnewswire.com
NVS
|
News
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
8.45%
|
O:
1.82%
H:
0.07%
C:
-1.0%
STAA
|
$46.79
0.97%
0.96%
380K
|
Health Technology
|
-29.68%
|
O:
0.52%
H:
0.29%
C:
-4.91%
ocular
state
diabetic
diabetes
Diabetic Neuropathy Drugs Market: Segmentation by product (calcium channel alpha-2-delta ligand, SNRIs and TCAs, and others) and geography (North America, Europe, Asia, and ROW)--Forecast till 2025|Technavio
Published:
2022-02-07
(Crawled : 10:00)
- prnewswire.com
ALPMF
|
News
|
$9.594
43.47%
2.2K
|
Health Technology
|
-42.79%
|
O:
7.04%
H:
0.0%
C:
-5.13%
AZNCF
|
$140.15
-4.19%
560
|
Health Technology
|
22.41%
|
O:
2.69%
H:
0.5%
C:
-1.76%
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
9.94%
|
O:
1.0%
H:
0.59%
C:
0.59%
ALPMY
|
News
|
$9.46
-1.11%
500K
|
Manufacturing
|
-46.04%
|
O:
1.1%
H:
0.69%
C:
0.0%
NVS
|
News
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
7.97%
|
O:
1.03%
H:
0.0%
C:
0.0%
AZN
|
$68.36
-0.25%
-0.25%
4M
|
Health Technology
|
21.32%
|
O:
-0.14%
H:
1.01%
C:
0.87%
america
europe
drug
diabetic
diabetes
Diabetic Macular Edema Market size worth $ 4.87 Billion, Globally, by 2028 at 2.86% CAGR: Verified Market Research®
Published:
2021-10-07
(Crawled : 13:15)
- prnewswire.com
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
15.09%
|
O:
2.72%
H:
0.1%
C:
0.1%
NVS
|
News
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
13.8%
|
O:
0.62%
H:
1.0%
C:
0.22%
KOD
|
$3.475
-3.47%
-3.6%
570K
|
Health Technology
|
-96.44%
|
O:
0.34%
H:
4.38%
C:
2.23%
research
macular
diabetic
diabetes
Global Diabetic Nephropathy Treatment Market to Reach $3.5 Billion by 2026
Published:
2021-10-06
(Crawled : 16:00)
- prnewswire.com
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
14.19%
|
O:
0.18%
H:
0.0%
C:
-0.96%
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
-39.93%
|
O:
-0.61%
H:
0.33%
C:
-0.1%
NVS
|
News
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
13.75%
|
O:
-0.55%
H:
0.71%
C:
0.5%
ABT
|
News
|
$105.27
-0.6%
-0.15%
7.3M
|
Health Technology
|
-6.86%
|
O:
-0.11%
H:
0.7%
C:
0.64%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-4.57%
|
O:
-0.87%
H:
0.8%
C:
0.63%
RETA
|
$172.36
0.02%
0.03%
0
|
Health Technology
|
74.52%
|
O:
-0.77%
H:
1.42%
C:
-1.5%
treatment
nephropathy
diabetic
diabetes
Gainers vs Losers
64%
36%
Top 10 Gainers
AGBA
|
$1.02
155.0%
57.94%
120M
|
Finance
ZCMD
|
$2.86
108.76%
52.1%
2.3M
|
Commercial Services
INVO
|
$1.555
104.6%
51.13%
5M
|
Health Technology
ISPC
|
$0.437
105.16%
49.53%
37M
|
Professional, Scientific, and T...
WLGS
|
$0.92
84.0%
45.65%
1.6M
|
OST
|
$0.499
21.38%
45.26%
1.9M
|
XPON
|
$3.1
60.62%
37.74%
17M
|
TIRX
|
$0.7
44.39%
30.74%
58M
|
BNTC
|
$6.92
44.17%
30.64%
3.5M
|
Health Technology
GGE
|
$0.035
19.86%
29.3%
64M
|
Your saved searches
Save your searches and get alerts when important news are released.